Skip to Main Content

Paper Details

Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.
Leuk Lymphoma
14
2017
Author NameAffiliation
Paulo Vidal Campreghera Department of Hematology and Clinical Pathology , Research Institute, Hospital Israelita Albert Einstein
Paulo Vidal Campregherb Foundation Medicine
Paulo Vidal CampregherUniversity of Campinas (Hemocentro - Unicamp)
Siraj M Alib Foundation Medicine
Vincent A Millerb Foundation Medicine
  • 1 - 5

Datasets

Release 1.2